Meanwhile, the HHS website scrubbed search results for the word "abortion," and ReproductiveRights.gov -- a site the Biden ...

The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.

A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer ...

The U.S. Food and Drug Administration banned Red No. 3 last dye, leading those to think Red Dye No. 40 could be next. How are ...

Discover which popular foods will be affected by the FDA's new ban on Red No. 3, the synthetic dye that adds a vibrant pop of ...

The test employs a combination of tumour-agnostic next-generation sequencing and personalised tumour-informed droplet PCR ...

Inhibrx Biosciences , Inc. (NASDAQ:INBX), a clinical-stage biopharmaceutical company valued at $205.41 million, is navigating a critical phase in its development as it advances its oncology pipeline.

GRAIL is advancing blood-based cancer detection with Galleri. Find out why GRAL stock’s future hinges on successful trials and regulatory approval.

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell ...

The U.S. Food and Drug Administration said on Wednesday it was adding a warning about the risk of a rare but serious allergic ...

During his presentation at the J.P. Morgan Healthcare Conference last week, Incyte CEO Hervé Hoppenot took investors on a ...